Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)
Clinical trial NCT07495579 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07495579
- Sponsor
- Asan Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-04-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.